How Much Did J&S Studies Raise?
Funding & Key Investors

J&S Studies, a long-standing pillar in the clinical research sector, has successfully secured a significant capital injection, bringing its total funding to $143K. This latest infusion of $143K represents a major strategic investment designed to bolster the firm's operational capacity and expand its reach within the competitive landscape of pharmaceutical trial management. By leveraging this financial backing, the organization is well-positioned to accelerate its research throughput and enhance its service offerings for global pharmaceutical partners.

What is J&S Studies?

J&S Studies
Business ServicesResearch & Development

Established in 1985 and headquartered in College Station, Texas, J&S Studies operates as an independently owned clinical research facility with a deep-rooted history in medical advancement. The company provides comprehensive trial services across diverse therapeutic areas, including dermatology, family medicine, and infectious diseases. By maintaining a robust patient database and employing a highly skilled team of study coordinators, J&S Studies has carved out a reputation for reliability and efficiency. Their market position is defined by their ability to bridge the gap between complex clinical requirements and the practical execution of trials, serving as a critical partner for research organizations and pharmaceutical developers seeking high-quality data collection and patient enrollment services.

How much funding has J&S Studies raised?

J&S Studies has raised a total of $143K across 1 funding round:

2021

Debt

$143K

Debt (2021): $143K with participation from PPP

Key Investors in J&S Studies

PPP

Public-Private Partnership

What's next for J&S Studies?

With this late-stage financing, J&S Studies is poised to transition into a new phase of institutional growth. The strategic allocation of these funds will likely focus on scaling infrastructure to accommodate more complex, multi-site clinical trials and upgrading digital patient management systems to improve enrollment velocity. As the clinical research industry faces increasing pressure for faster drug development cycles, J&S Studies is strategically aligning its resources to meet these demands. Future initiatives will likely involve expanding their therapeutic expertise and strengthening their technological backbone to maintain their competitive edge in the evolving landscape of medical research and development.

See full J&S Studies company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesCall Centers & Business CentersAdvertising Networks
Business ServicesResearch & DevelopmentHealthcare SoftwareManufacturingMedical Devices & EquipmentSoftware
Business ServicesSoftware TestingNetworking SoftwareSoftwareStorage & System Management Software
Business ServicesProject Management

Frequently Asked Questions Regarding J&S Studies Financial Insights

What are the most recent funding rounds that J&S Studies has completed, and what were the funding rounds?
J&S Studies has recently completed 1 funding rounds: Debt on Feb 25, 2021.
What is the total amount of funding J&S Studies has raised to date?
J&S Studies has raised a total of $143K in funding to date.
How many funding rounds has J&S Studies completed?
J&S Studies has completed 1 funding rounds.
How much funding did J&S Studies raise in its most recent funding round?
J&S Studies raised $143K in its most recent funding round.
Who are the lead investors in J&S Studies's latest funding round?
The lead investor in J&S Studies's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in J&S Studies's history?
The largest funding round in J&S Studies's history was $143K.
See more information about J&S Studies